- Home
- APRE vs RCG Comparison
APRE vs RCG Comparison
Compare APRE & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- RCG
- Stock Information
- Founded
- APRE 2006
- RCG 1994
- Country
- APRE United States
- RCG United States
- Employees
- APRE N/A
- RCG N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- RCG Investment Managers
- Sector
- APRE Health Care
- RCG Finance
- Exchange
- APRE Nasdaq
- RCG Nasdaq
- Market Cap
- APRE 15.8M
- RCG 15.6M
- IPO Year
- APRE 2019
- RCG N/A
- Fundamental
- Price
- APRE $3.05
- RCG $2.47
- Analyst Decision
- APRE Strong Buy
- RCG
- Analyst Count
- APRE 2
- RCG 0
- Target Price
- APRE $15.50
- RCG N/A
- AVG Volume (30 Days)
- APRE 22.6K
- RCG 5.9K
- Earning Date
- APRE 11-07-2024
- RCG 01-01-0001
- Dividend Yield
- APRE N/A
- RCG 0.98%
- EPS Growth
- APRE N/A
- RCG N/A
- EPS
- APRE N/A
- RCG N/A
- Revenue
- APRE $1,310,839.00
- RCG N/A
- Revenue This Year
- APRE $134.21
- RCG N/A
- Revenue Next Year
- APRE N/A
- RCG N/A
- P/E Ratio
- APRE N/A
- RCG N/A
- Revenue Growth
- APRE 130.31
- RCG N/A
- 52 Week Low
- APRE $2.15
- RCG $1.52
- 52 Week High
- APRE $8.85
- RCG $1.90
- Technical
- Relative Strength Index (RSI)
- APRE 43.20
- RCG 49.06
- Support Level
- APRE $3.02
- RCG $2.48
- Resistance Level
- APRE $3.39
- RCG $2.55
- Average True Range (ATR)
- APRE 0.30
- RCG 0.07
- MACD
- APRE -0.01
- RCG -0.03
- Stochastic Oscillator
- APRE 3.85
- RCG 3.23
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, Oil and Gas, medical chemicals, botanical products, and others.